{"id":"https://openalex.org/W2097337104","doi":"https://doi.org/10.1097/01.asn.0000032544.37147.ae","title":"Renal and Cardiovascular Protection in Type 2 Diabetes Mellitus","display_name":"Renal and Cardiovascular Protection in Type 2 Diabetes Mellitus","publication_year":2002,"publication_date":"2002-11-01","ids":{"openalex":"https://openalex.org/W2097337104","doi":"https://doi.org/10.1097/01.asn.0000032544.37147.ae","mag":"2097337104","pmid":"https://pubmed.ncbi.nlm.nih.gov/12466318"},"language":"en","primary_location":{"id":"doi:10.1097/01.asn.0000032544.37147.ae","doi":"https://doi.org/10.1097/01.asn.0000032544.37147.ae","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.asn.0000032544.37147.ae","pdf_url":null,"source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074090777","display_name":"Giacomo Deferrari","orcid":"https://orcid.org/0000-0001-8703-2416","observed_orcids":["https://orcid.org/0000-0001-8703-2416"]},"institutions":[{"id":"https://openalex.org/I83816512","display_name":"University of Genoa","ror":"https://ror.org/0107c5v14","country_code":"IT","type":"education","lineage":["https://openalex.org/I83816512"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Giacomo Deferrari","raw_affiliation_strings":["Department of Internal Medicine, Section of Nephrology and Dialysis, University of Genoa, Genoa, Italy. gildaplm@unige.it","Fax: 39-010-353-8959","to Dr. Giacomo Deferrari, Department of Internal Medicine, Viale Benedetto XV, 6 16123 Genoa, Italy. Phone: 39-010-353-8959"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Section of Nephrology and Dialysis, University of Genoa, Genoa, Italy. gildaplm@unige.it","institution_ids":["https://openalex.org/I83816512"]},{"raw_affiliation_string":"Fax: 39-010-353-8959","institution_ids":[]},{"raw_affiliation_string":"to Dr. Giacomo Deferrari, Department of Internal Medicine, Viale Benedetto XV, 6 16123 Genoa, Italy. Phone: 39-010-353-8959","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011229355","display_name":"Maura Ravera","orcid":"https://orcid.org/0000-0003-3856-6168","observed_orcids":["https://orcid.org/0000-0003-3856-6168"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Maura Ravera","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060102935","display_name":"Luca Deferrari","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Luca Deferrari","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062581593","display_name":"Simone Vettoretti","orcid":"https://orcid.org/0000-0002-1040-4952","observed_orcids":["https://orcid.org/0000-0002-1040-4952"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Simone Vettoretti","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086626117","display_name":"Elena Ratto","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Elena Ratto","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5109148399","display_name":"Denise Parodi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Denise Parodi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5011229355","https://openalex.org/A5062581593","https://openalex.org/A5074090777","https://openalex.org/A5086626117","https://openalex.org/A5109148399"],"corresponding_institution_ids":["https://openalex.org/I83816512"],"apc_list":null,"apc_paid":null,"fwci":2.9239,"has_fulltext":false,"cited_by_count":53,"citation_normalized_percentile":{"value":0.90640871,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"13","issue":"suppl_3","first_page":"S224","last_page":"S229"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.004000000189989805,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9909999966621399},{"id":"https://openalex.org/keywords/diabetic-nephropathy","display_name":"diabetic nephropathy","score":0.996999979019165},{"id":"https://openalex.org/keywords/renal-protection","display_name":"renal protection","score":0.8519999980926514},{"id":"https://openalex.org/keywords/cardioprotection","display_name":"cardioprotection","score":0.7229999899864197},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.8679999709129333},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.996999979019165},{"id":"https://openalex.org/keywords/renin-angiotensin-aldosterone-system-inhibition","display_name":"renin-angiotensin-aldosterone system inhibition","score":0.8980000019073486},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.5329999923706055},{"id":"https://openalex.org/keywords/proteinuria","display_name":"proteinuria","score":0.9049999713897705},{"id":"https://openalex.org/keywords/end-stage-renal-disease","display_name":"end-stage renal disease","score":0.9409999847412109},{"id":"https://openalex.org/keywords/irbesartan","display_name":"irbesartan","score":0.8169999718666077},{"id":"https://openalex.org/keywords/losartan","display_name":"losartan","score":0.9980000257492065},{"id":"https://openalex.org/keywords/heart-failure-hospitalization","display_name":"heart failure hospitalization","score":0.753000020980835},{"id":"https://openalex.org/keywords/left-ventricular-hypertrophy","display_name":"left ventricular hypertrophy","score":0.8970000147819519},{"id":"https://openalex.org/keywords/microvascular-complications","display_name":"microvascular complications","score":0.5180000066757202},{"id":"https://openalex.org/keywords/macrovascular-complications","display_name":"macrovascular complications","score":0.8270000219345093}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9032699465751648},{"id":"https://openalex.org/C2780288358","wikidata":"https://www.wikidata.org/wiki/Q410074","display_name":"Losartan","level":4,"score":0.7473970651626587},{"id":"https://openalex.org/C2779922275","wikidata":"https://www.wikidata.org/wiki/Q1129105","display_name":"Diabetic nephropathy","level":3,"score":0.7136329412460327},{"id":"https://openalex.org/C2779561371","wikidata":"https://www.wikidata.org/wiki/Q570197","display_name":"Proteinuria","level":3,"score":0.6553851366043091},{"id":"https://openalex.org/C2781184683","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Nephropathy","level":3,"score":0.6438499093055725},{"id":"https://openalex.org/C2780259554","wikidata":"https://www.wikidata.org/wiki/Q947266","display_name":"Irbesartan","level":3,"score":0.6004764437675476},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5862542986869812},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5809667110443115},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5562150478363037},{"id":"https://openalex.org/C2779611605","wikidata":"https://www.wikidata.org/wiki/Q288280","display_name":"ACE inhibitor","level":4,"score":0.45169445872306824},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.4059465527534485},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.35886988043785095},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.3274475336074829},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.30505019426345825},{"id":"https://openalex.org/C27016395","wikidata":"https://www.wikidata.org/wiki/Q128861","display_name":"Angiotensin-converting enzyme","level":3,"score":0.2818331718444824},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.2240281105041504}],"mesh":[{"descriptor_ui":"D002316","descriptor_name":"Cardiotonic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007674","descriptor_name":"Kidney Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D057911","descriptor_name":"Angiotensin Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1097/01.asn.0000032544.37147.ae","doi":"https://doi.org/10.1097/01.asn.0000032544.37147.ae","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.asn.0000032544.37147.ae","pdf_url":null,"source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"},{"id":"pmid:12466318","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12466318","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology : JASN","raw_type":"Journal Article"},{"id":"pmh:oai:boa.unimib.it:10281/547884","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/10281/547884","pdf_url":null,"source":{"id":"https://openalex.org/S4306401259","display_name":"BOA (University of Milano-Bicocca)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I66752286","host_organization_name":"University of Milano-Bicocca","host_organization_lineage":["https://openalex.org/I66752286"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:iris.unige.it:11567/206248","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/11567/206248","pdf_url":null,"source":{"id":"https://openalex.org/S4377196291","display_name":"CINECA IRIS Institutial Research Information System (University of Genoa)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I83816512","host_organization_name":"University of Genoa","host_organization_lineage":["https://openalex.org/I83816512"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":52,"referenced_works":["https://openalex.org/W22189248","https://openalex.org/W1604542334","https://openalex.org/W1965476867","https://openalex.org/W1966972471","https://openalex.org/W1972492725","https://openalex.org/W1977075739","https://openalex.org/W1982920623","https://openalex.org/W1986924251","https://openalex.org/W1987340119","https://openalex.org/W1993642160","https://openalex.org/W1995904639","https://openalex.org/W1999904792","https://openalex.org/W2004164169","https://openalex.org/W2005685765","https://openalex.org/W2007063002","https://openalex.org/W2008168710","https://openalex.org/W2010222728","https://openalex.org/W2022854575","https://openalex.org/W2032425666","https://openalex.org/W2044773944","https://openalex.org/W2045161455","https://openalex.org/W2045279107","https://openalex.org/W2045843480","https://openalex.org/W2049397775","https://openalex.org/W2053330911","https://openalex.org/W2056976690","https://openalex.org/W2070747248","https://openalex.org/W2073935745","https://openalex.org/W2074391521","https://openalex.org/W2087798038","https://openalex.org/W2088406345","https://openalex.org/W2093679117","https://openalex.org/W2103895188","https://openalex.org/W2128864868","https://openalex.org/W2133217116","https://openalex.org/W2136114804","https://openalex.org/W2137408480","https://openalex.org/W2138119952","https://openalex.org/W2148608243","https://openalex.org/W2149482089","https://openalex.org/W2214182381","https://openalex.org/W2331322517","https://openalex.org/W2413195481","https://openalex.org/W2414167269","https://openalex.org/W2465139524","https://openalex.org/W2615684303","https://openalex.org/W2923575032","https://openalex.org/W2993043209","https://openalex.org/W3021250193","https://openalex.org/W3198570063","https://openalex.org/W4237181509","https://openalex.org/W4242344507"],"related_works":["https://openalex.org/W7061462815","https://openalex.org/W2126468069","https://openalex.org/W7095070387","https://openalex.org/W2142922621","https://openalex.org/W1965571951","https://openalex.org/W1970478577","https://openalex.org/W2088303495","https://openalex.org/W1925758251","https://openalex.org/W2137999820","https://openalex.org/W1986255254"],"abstract_inverted_index":{"Aggressive":[0],"treatment":[1,42,297],"of":[2,30,43,70,127,137,144,166,217,259,298,341],"hypertension":[3,44,263],"is":[4,156,244],"effective":[5,61,158,195,246,274],"in":[6,13,40,66,73,86,95,146,162,170,180,200,208,219,224,250,256,275,285,313,322,338,352],"reducing":[7,67,201,251,281],"both":[8,74,276],"microvascular":[9],"and":[10,17,45,77,169,187,254,264,280,296,329],"macrovascular":[11],"complications":[12],"type":[14,75,78,96,117,147,209,286,305,314],"2":[15,79,97,148,210,287,315],"diabetes,":[16,316],"target":[18],"BP":[19,178],"less":[20],"than":[21,62,159,196,247],"130/85":[22],"or":[23,140],"130/80":[24],"mmHg":[25],"are":[26,59,193,301,309,318],"now":[27,302,332],"recommended.":[28],"Inhibition":[29],"renin":[31],"angiotensin":[32,129],"aldosterone":[33],"system":[34],"(RAAS)":[35],"plays":[36],"an":[37],"essential":[38],"role":[39,111],"the":[41,68,125,135,142,164,172,238,291,294,310,334,349],"diabetes-related":[46],"complications.":[47],"Studies":[48],"focusing":[49],"on":[50],"renal":[51,205,278],"end-points":[52],"suggest":[53],"that":[54,154,191,242],"angiotensin-converting":[55],"enzyme":[56],"inhibitors":[57],"(ACE-I)":[58],"more":[60,157,194,245],"other":[63],"traditional":[64,197],"agents":[65],"onset":[69],"clinical":[71,138,167],"proteinuria":[72,139,168],"1":[76,118,306],"diabetic":[80,98,211,260,288,299],"patients":[81,99,181,212,233,261],"with":[82,100,116,182,213,235,262],"incipient":[83,183],"nephropathy,":[84],"mainly":[85],"normotensive":[87],"ones":[88],"(secondary":[89],"prevention).":[90],"However,":[91],"several":[92],"small":[93],"trials":[94,123,189],"overt":[101,214],"nephropathy":[102,145,215,300],"(tertiary":[103],"prevention)":[104],"failed":[105],"to":[106,174,272],"demonstrate":[107],"a":[108,222,257],"specific":[109],"renoprotective":[110],"for":[112,176,226,231,293],"ACE-I,":[113],"at":[114],"variance":[115],"diabetes.":[119,149],"Three":[120],"recent":[121],"large":[122],"address":[124],"question":[126],"whether":[128],"II":[130],"receptor":[131],"blockers":[132],"(ARB)":[133],"prevent":[134],"development":[136,165],"delay":[141],"progression":[143,202,282],"The":[150,185],"IRMA":[151],"study":[152,240],"showed":[153,190,241],"irbesartan":[155],"conventional":[160,248],"therapy":[161,249],"preventing":[163,277],"favoring":[171],"regression":[173],"normoalbuminuria":[175],"comparable":[177],"control":[179],"nephropathy.":[184],"IDNT":[186],"RENAAL":[188],"ARB":[192,270,317,344],"antihypertensive":[198],"therapies":[199],"toward":[203,283],"end-stage":[204],"failure":[206,228],"(ESRF)":[207],"independently":[216],"changes":[218],"BP.":[220],"Moreover,":[221],"reduction":[223],"hospitalizations":[225],"heart":[227],"was":[229],"demonstrated":[230],"ARB-treated":[232],"compared":[234],"placebo.":[236],"Furthermore,":[237],"LIFE":[239],"losartan":[243],"cardiovascular":[252,353],"morbidity":[253],"mortality":[255],"cohort":[258],"left":[265],"ventricular":[266],"hypertrophy.":[267],"In":[268,304],"conclusion,":[269],"seem":[271],"be":[273,346],"damage":[279],"ESRF":[284],"patients.":[289],"Thus,":[290],"guidelines":[292],"prevention":[295,324,340,354],"changed.":[303],"diabetes":[307],"ACE-I":[308,328],"first-choice":[311,320,336,350],"drug;":[312],"considered":[319,347],"drugs":[321],"secondary":[323],"as":[325,327,348,356,358],"well":[326,357],"have":[330],"been":[331],"elected":[333],"unique":[335],"drug":[337,351],"tertiary":[339],"ESRF.":[342],"Finally,":[343],"should":[345],"too,":[355],"ACE-I.":[359]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":4},{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}